The effects of antidepressants on psychomotor function with particular reference to reboxetine

European Neuropsychopharmacology

Volumn 7, Issue SUPPL. 1, 1997, Pages

  Hindmarch, I ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Cognitive function; Depression; Psychomotor function; Reboxetine; Selective serotonin reuptake inhibitors (SSRIs); Tricyclic antidepressants (TCAs)

Indexed keywords

ALCOHOL; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DESIPRAMINE; DOSULEPIN; FLUOXETINE; FLUVOXAMINE; MIANSERIN; MILNACIPRAN; NOMIFENSINE; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; PSYCHOTROPIC AGENT; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; ZIMELDINE;

ACCIDENT; CLINICAL TRIAL; COGNITION; COMPLICATION; CONFERENCE PAPER; CRITICAL FLICKER FUSION; DAILY LIFE ACTIVITY; DEPRESSION; DRIVING ABILITY; DRUG EFFECT; DRUG SELECTIVITY; HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RESPONSE TIME; SIDE EFFECT;

EID: 0031004810     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00416-1     Document Type: Conference Paper

References (31)

1. J. Angst Epidemiology of depression Psychopharmacology 102 1992 S71 S74
2. M. Asberg L. Traskmann P. Thoren 5-Hydroxyindole acetic acid in cerebrospinal fluid – a biochemical suicide predictor? Arch. Gen. Psychiatry 33 1976 1193 1197
3. A. Atwal A. Chordia A. Wanchoo J. Jain Cognitive test performance correlates of CFF Int. J. Curr. Psychol. Res. 3 1988 62 63
4. P.A. Berry R. Burtles D.J. Grubb M.V. Hoare An evaluation of the effects of clobazam on human motor co-ordination, mental activity and mood Br. J. Pharmacol. 1 1974 346
5. B. Biehl Studies of clobazam and car-driving Br. J. Clin. Pharmacol. 7 1979 S85 S90
6. D. Currie K. Hashemi J. Fothergill A. Findlay B. Harris I. Hindmarch The use of antidepressants and benzodiazepines in the perpetrators and victims of accidents Occup. Med. 45 6 1995 323 325
7. C. De Montagny Y. Chaput P. Blier Modification of serotonergic neuronal properties by long-term treatment with serotonin reuptake blockers J. Clin. Psychiatry 51 Suppl. 12 1990 38 42
8. D.B. Fairweather J.S. Kerr D.A. Harrison C.A. Moon I. Hindmarch A double-blind comparison of the effects of fluoxetine and amitriptyline on cognitive function in elderly depressed patients Hum. Psychopharmacol. 8 1993 41 47
9. D.J. Greenblatt E.M. Sellers R.I. Shader Drug disposition in old age N. Engl. J. Med. 306 1982 1081 1087
10. A.S. Hale A medical model for community care? J. Ment. Health 3 1994 147 148
11. A.S. Hale N.R. Pinninti Critical flicker fusion threshold and anticholinergic effects of chronic antidepressant treatment in remitted depressives J. Psychopharmacol. 9 3 1995 258 266
12. G.W. Hanks The effects of amitriptyline and nomifensine on critical flicker fusion threshold in an elderly patient population Nomifensine, Royal Society of Medicine International Congress and Symposium Series RSM, London, 70 1984 95 98
13. I. Hindmarch A 1,4-benzodiazepine, temazepam: its effects on sleep and behaviour Arzneim.-Forsch. Drug Res. 25 11 1975 1836 1839
14. I. Hindmarch Critical flicker fusion: the effect of psychotropic compounds Pharmacopsychiatria. 15 1982 44 48
15. I. Hindmarch Psychomotor function and psychoactive drugs Br. J. Clin. Pharmacol. 10 1980 189 209
16. I. Hindmarch A pharmacological profile of fluoxetine and other antidepressants on aspects of skilled performance and car handling ability Br. J. Psychiatry 153 suppl. 3 1988 99 104
17. I. Hindmarch C. Harrison The effects of paroxetine and other antidepressants in combination with alcohol in psychomotor activity related to car driving Hum. Psychopharmacol. 3 1988 13 20
18. J.S. Kerr J. Powell I. Hindmarch The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance Br. J. Clin. Pharmacol. 42 1996 239 241
19. J.S. Kerr I. Hindmarch N. Sherwood Correlation between doses of oxazepam and their effects on performance of a standardised test battery Eur. J. Clin. Pharmacol. 42 1991 507 510
20. Kerr and Hindmarch, 1992
21. B.E. Leonard Noradrenaline in basic models of depression Eur. J. Neuropsychopharmacol. 1997 S11 S16 This volume
22. S.R. Lord K.J. Anstey P. Williams J.A. Ward Psychoactive medication use, sensory-motor function and falls in older women Br. J. Clin. Pharmacol. 39 1995 227 234
23. R.D. MacPherson J. Perl G.A. Starmer Self-reported drug usage and crash incidence in breathalysed drivers Accid. Anal. Prev. 16 1984 139 148
24. J.B. McDonald The role of drugs in falls in the elderly Clin. Geriatr. Med. 1 1985 621 636
25. A.C. Parrott CFF thresholds and their relationship to other measures of alertness Pharmacopsychiatria. 15 1 1982 39 44
26. W.A. Ray R.L. Fought M.D. Decker Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers Am. J. Epidemiol. 136 7 1992 873 883
27. W.A. Ray M.R. Griffin W. Schaffner D.K. Baugh L.J. Melton Psychotropic drug use and the risk of hip fracture N. Engl. J. Med. 316 1987 363 369
28. M. Sakulsripong H.V. Curran M. Lader Does tolerance develop to the sedative and amnesic effects of antidepressants? A comparison of amitriptyline, trazodone and placebo Eur. J. Clin. Pharmacol. 49 1991 43 48
29. J. Scott D. Eccleston R. Boyes Can we predict the persistance of depression? Br. J. Psychiatry 161 1992 633 637
30. K.G. Sobel G.M. McCart Geriatrics and Gerontology: drug use and accidental falls in an intermediate care facility Drug Intell. Clin. Pharmacol. 17 1983 (July-August) 539 542
31. D. Widlocher Psychomotor retardation: clinical, theoretical and psychometric aspects Psychiatr. Clin. North. Am. 6 1983 27 39